Filana Therapeutics board member Michael O'Donnell resigns effective at 2026 annual meeting

FILANA THERAPEUTICS, INC.

Michael O'Donnell notified Filana's Board of his resignation on April 22, 2026.
Resignation is effective at the conclusion of the 2026 annual meeting of stockholders.
O'Donnell will continue to serve as a director until the effective date.
Resignation was not due to any disagreement with Company, management, or Board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.